FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia

Fanconi anemia is a rare hereditary disease showing genetic heterogeneity due to a variety of mutations in genes involved in DNA repair pathways, which may lead to different clinical manifestations. Phenotypic variability makes diagnosis difficult based only on clinical manifestations, therefore lab...

Full description

Bibliographic Details
Main Authors: D.V. Pilonetto, N.F. Pereira, M.A. Bitencourt, N.I.R. Magdalena, E.R. Vieira, L.B.A. Veiga, I.J. Cavalli, R.C. Ribeiro, R. Pasquini
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2009-03-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000300004
_version_ 1818026574059929600
author D.V. Pilonetto
N.F. Pereira
M.A. Bitencourt
N.I.R. Magdalena
E.R. Vieira
L.B.A. Veiga
I.J. Cavalli
R.C. Ribeiro
R. Pasquini
author_facet D.V. Pilonetto
N.F. Pereira
M.A. Bitencourt
N.I.R. Magdalena
E.R. Vieira
L.B.A. Veiga
I.J. Cavalli
R.C. Ribeiro
R. Pasquini
author_sort D.V. Pilonetto
collection DOAJ
description Fanconi anemia is a rare hereditary disease showing genetic heterogeneity due to a variety of mutations in genes involved in DNA repair pathways, which may lead to different clinical manifestations. Phenotypic variability makes diagnosis difficult based only on clinical manifestations, therefore laboratory tests are necessary. New advances in molecular pathogenesis of this disease led researchers to develop a diagnostic test based on Western blot for FANCD2. The objective of the present study was to determine the efficacy of this method for the diagnosis of 84 Brazilian patients with Fanconi anemia, all of whom tested positive for the diepoxybutane test, and 98 healthy controls. The FANCD2 monoubiquitinated isoform (FANCDS+/FANCD2L-) was not detected in 77 patients (91.7%). In 2 patients (2.4%), there was an absence of both the monoubiquitinated and the non-ubiquitinated proteins (FANCD2S-/FANCD2L-) and 5 patients (5.9%) had both isoforms (FANCD2S+/FANCD2L+). This last phenotype suggests downstream subtypes or mosaicism. All controls were diepoxybutane negative and were also negative on the FANCD2 Western blot. The Western blot for FANCD2 presented a sensitivity of 94% (79/84) and specificity of 100% (98/98). This method was confirmed as an efficient approach to screen Brazilian patients with deleterious mutations on FANCD2 (FANCD2S-/FANCD2L-) or other upstream genes of the FA/BRCA pathway (FANCDS+/FANCD2L-), to confirm the chromosome breakage test and to classify patients according to the level of FA/BRCA pathway defects. However, patients showing both FANCD2 isoforms (FANCD2S+/FANCD2L+) require additional studies to confirm mutations on downstream Fanconi anemia genes or the presence of mosaicism.
first_indexed 2024-12-10T04:34:10Z
format Article
id doaj.art-6bae605d42454d27a4378dc76c24c16f
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-10T04:34:10Z
publishDate 2009-03-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-6bae605d42454d27a4378dc76c24c16f2022-12-22T02:02:04ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2009-03-01423237243FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemiaD.V. PilonettoN.F. PereiraM.A. BitencourtN.I.R. MagdalenaE.R. VieiraL.B.A. VeigaI.J. CavalliR.C. RibeiroR. PasquiniFanconi anemia is a rare hereditary disease showing genetic heterogeneity due to a variety of mutations in genes involved in DNA repair pathways, which may lead to different clinical manifestations. Phenotypic variability makes diagnosis difficult based only on clinical manifestations, therefore laboratory tests are necessary. New advances in molecular pathogenesis of this disease led researchers to develop a diagnostic test based on Western blot for FANCD2. The objective of the present study was to determine the efficacy of this method for the diagnosis of 84 Brazilian patients with Fanconi anemia, all of whom tested positive for the diepoxybutane test, and 98 healthy controls. The FANCD2 monoubiquitinated isoform (FANCDS+/FANCD2L-) was not detected in 77 patients (91.7%). In 2 patients (2.4%), there was an absence of both the monoubiquitinated and the non-ubiquitinated proteins (FANCD2S-/FANCD2L-) and 5 patients (5.9%) had both isoforms (FANCD2S+/FANCD2L+). This last phenotype suggests downstream subtypes or mosaicism. All controls were diepoxybutane negative and were also negative on the FANCD2 Western blot. The Western blot for FANCD2 presented a sensitivity of 94% (79/84) and specificity of 100% (98/98). This method was confirmed as an efficient approach to screen Brazilian patients with deleterious mutations on FANCD2 (FANCD2S-/FANCD2L-) or other upstream genes of the FA/BRCA pathway (FANCDS+/FANCD2L-), to confirm the chromosome breakage test and to classify patients according to the level of FA/BRCA pathway defects. However, patients showing both FANCD2 isoforms (FANCD2S+/FANCD2L+) require additional studies to confirm mutations on downstream Fanconi anemia genes or the presence of mosaicism.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000300004Fanconi anemiaFANCD2 Western blotDiepoxybutane testMonoubiquitinationImmunoblotting
spellingShingle D.V. Pilonetto
N.F. Pereira
M.A. Bitencourt
N.I.R. Magdalena
E.R. Vieira
L.B.A. Veiga
I.J. Cavalli
R.C. Ribeiro
R. Pasquini
FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
Brazilian Journal of Medical and Biological Research
Fanconi anemia
FANCD2 Western blot
Diepoxybutane test
Monoubiquitination
Immunoblotting
title FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_full FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_fullStr FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_full_unstemmed FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_short FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_sort fancd2 western blot as a diagnostic tool for brazilian patients with fanconi anemia
topic Fanconi anemia
FANCD2 Western blot
Diepoxybutane test
Monoubiquitination
Immunoblotting
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000300004
work_keys_str_mv AT dvpilonetto fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT nfpereira fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT mabitencourt fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT nirmagdalena fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT ervieira fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT lbaveiga fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT ijcavalli fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT rcribeiro fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT rpasquini fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia